Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Research

Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence

Authors: Isabel Morales Barroso, Lorena López-Cerero, María Dolores Navarro, Belén Gutiérrez-Gutiérrez, Alvaro Pascual, Jesús Rodríguez-Baño

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Escherichia coli sequence type 131 (ST131) is a successful clonal group that has dramatically spread during the last decades and is considered an important driver for the rapid increase of quinolone resistance in E. coli.

Methods

Risk factors for rectal colonization by ST131 Escherichia coli (irrespective of ESBL production) were investigated in 64 household members (18 were colonized) and 54 hospital contacts (HC; 10 colonized) of 34 and 30 index patients with community and nosocomial infection due to these organisms, respectively, using multilevel analysis with a p limit of < 0.1.

Result

Colonization among household members was associated with the use of proton-pump inhibitors (PPI) by the household member (OR = 3.08; 95% CI: 0.88–10.8) and higher age of index patients (OR = 1.05; 95% CI; 1.01–1.10), and among HC, with being bed-ridden (OR = 21.1; 95% CI: 3.61–160.0) and having a urinary catheter (OR = 8.4; 95% CI: 0.87–76.9).

Conclusion

Use of PPI and variables associated with higher need of person-to-person contact are associated with increased risk of rectal colonization by ST131. These results should be considered for infection control purposes.
Literature
2.
go back to reference Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014;58:4997–5004.CrossRefPubMedPubMedCentral Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014;58:4997–5004.CrossRefPubMedPubMedCentral
3.
go back to reference Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Res. 2017;6. Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Res. 2017;6.
4.
go back to reference Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris. France J Clin Microbiol. 2008;46:3900–5.CrossRefPubMed Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris. France J Clin Microbiol. 2008;46:3900–5.CrossRefPubMed
5.
go back to reference López-Cerero L, Bellido Mdel M, Serrano L, Liró J, Cisneros JM, Rodríguez-Baño J, Pascual A. Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance. Enferm Infecc Microbiol Clin. 2013;31:385–8.CrossRefPubMed López-Cerero L, Bellido Mdel M, Serrano L, Liró J, Cisneros JM, Rodríguez-Baño J, Pascual A. Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance. Enferm Infecc Microbiol Clin. 2013;31:385–8.CrossRefPubMed
6.
go back to reference Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A. Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018;24:618–23.CrossRefPubMed Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A. Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018;24:618–23.CrossRefPubMed
7.
go back to reference Clinical and Laboratory Standard Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 8th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2009. CLSI document M07eA7. Clinical and Laboratory Standard Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 8th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2009. CLSI document M07eA7.
8.
go back to reference Huizinga P, van den Bergh MK, van Rijen M, Willemsen I, Van ‘t Veer N, Kluytmans J. Proton Pump Inhibitor Use Is Associated With Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Rectal Carriage at Hospital Admission: A Cross-Sectional Study. Clin Infect Dis. 2017;64:361–3.CrossRefPubMed Huizinga P, van den Bergh MK, van Rijen M, Willemsen I, Van ‘t Veer N, Kluytmans J. Proton Pump Inhibitor Use Is Associated With Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Rectal Carriage at Hospital Admission: A Cross-Sectional Study. Clin Infect Dis. 2017;64:361–3.CrossRefPubMed
9.
go back to reference Talaminos A, López-Cerero L, Calvillo J, Pascual A, Roa LM, Rodríguez-Baño J. Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres. Epidemiol Infect. 2016;144:1974–82.CrossRefPubMed Talaminos A, López-Cerero L, Calvillo J, Pascual A, Roa LM, Rodríguez-Baño J. Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres. Epidemiol Infect. 2016;144:1974–82.CrossRefPubMed
10.
go back to reference Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, et al. Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis. Open Forum Infect Dis. 2016;3:ofw129.CrossRefPubMedPubMedCentral Johnson JR, Davis G, Clabots C, Johnston BD, Porter S, DebRoy C, et al. Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis. Open Forum Infect Dis. 2016;3:ofw129.CrossRefPubMedPubMedCentral
11.
go back to reference Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, et al. Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli. Diagn Microbiol Infect Dis. 2017;87:275–80.CrossRefPubMed Han JH, Garrigan C, Johnston B, Nachamkin I, Clabots C, Bilker WB, et al. Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli. Diagn Microbiol Infect Dis. 2017;87:275–80.CrossRefPubMed
12.
go back to reference Burgess MJ, Johnson JR, Porter SB, Johnston B, Clabots C, Lahr BD, et al. Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli. Open Forum Infect Dis. 2015;2:ofv011.CrossRefPubMedPubMedCentral Burgess MJ, Johnson JR, Porter SB, Johnston B, Clabots C, Lahr BD, et al. Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli. Open Forum Infect Dis. 2015;2:ofv011.CrossRefPubMedPubMedCentral
13.
go back to reference López-Cerero L, Navarro MD, Bellido M, Martín-Peña A, Viñas L, Cisneros JM, et al. Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. J Antimicrob Chemother. 2014;69:809–14.CrossRefPubMed López-Cerero L, Navarro MD, Bellido M, Martín-Peña A, Viñas L, Cisneros JM, et al. Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. J Antimicrob Chemother. 2014;69:809–14.CrossRefPubMed
Metadata
Title
Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence
Authors
Isabel Morales Barroso
Lorena López-Cerero
María Dolores Navarro
Belén Gutiérrez-Gutiérrez
Alvaro Pascual
Jesús Rodríguez-Baño
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-018-0427-9

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue